Top

Published in:

01-02-2011 | Original Communication

Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings

Authors: Yongmei Li, Chun Zeng, Tianyou Luo

Published in: Journal of Neurology | Issue 2/2011

Abstract

Paroxysmal dysarthria (PD) and paroxysmal dysarthria–ataxia (PDA) syndromes are uncommon symptoms of the neurological dysfunction in multiple sclerosis (MS). We describe two patients who had clinically definite MS presented with symptomatic PD and PDA syndromes, respectively, related to demyelinating lesions. In one patient, the PD symptom was the initial manifestation of an acute episode. In the other patient, the episode of dysarthria was accompanied by ataxia disorders. Both patients had midbrain lesions at or below the level of the right red nucleus on magnetic resonance imaging (MRI), confirming that this area is critically involved. Both responded well to carbamazepine (CBZ).

Marcel C, Anheim M, Flamand-Rouvière C, Heran F, Masnou P, Boulay C, Mari I, Tranchant C, Roze E (2010) Symptomatic paroxysmal dysarthria–ataxia in demyelinating diseases. J Neurol 257:1369–1372CrossRefPubMed

Merson RM, Rolnick MI (1998) Speech-language pathology and dysphagia in multiple sclerosis. Phys Med Rehabil Clin N Am 9(3):631–641PubMed

Parker HL (1946) Periodic ataxia. Coll Pap Mayo Clin 38:642–645

Blanco Y, Compta Y, Graus F, Saiz A (2008) Midbrain lesions and paroxysmal dysarthria in multiple sclerosis. Mult Scler 14(5):694–697CrossRefPubMed

Tüzün E, Akman-Demir G, Eraksoy M (2001) Paroxysmal attacks in multiple sclerosis. Mult Scler 7(6):402–404PubMed

McDonald W, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neural 50:121–127CrossRef

Solaro C, Brichetto G, Battaglia MA, Mesmer Uccelli M, Mancardi GL (2005) Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci 25:307–310CrossRefPubMed

Khan OA, Olek MJ (1995) Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine. J Neurol Neurosurg Psychiatry 58:253–264CrossRefPubMed

Khan OA (1994) Treatment of paroxysmal symptoms in multiple sclerosis with ibuprofen. Neurology 44:571–572PubMed

10.

Matsui M, Tomimoto H, Sano K, Hashikawa K, Fukuyama H, Shibasaki H (2004) Paroxysmal dysarthria and ataxia after midbrain infarction. Neurology 63(2):345–347PubMed

11.

Hiraga A, Tanaka S, Kamitsukasa I (2010) Pure dysarthria due to an insular infarction. J Clin Neurosci 17:812–813CrossRefPubMed

12.

Kumral E, Çelebisoy M, Çelebisoy N, Canbaz DH, Calli C (2007) Dysarthria due to supratentorial and infratentorial ischemic stroke: a diffusion-weighted imaging study. Cerebrovasc Dis 23:331–338CrossRefPubMed

13.

Kraemer M, Berlit P (2010) Primary central nervous system vasculitis and moyamoya disease: similarities and differences. J Neurol 257:816–819CrossRefPubMed

Title: Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings
Authors: Yongmei Li
Chun Zeng
Tianyou Luo
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 2/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5748-4

At a glance: The STEP trials

Springer Medicine

Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Striatal dopamine function in a family with multiple SCA-3 phenotypes

Aphasia assessment and functional outcome prediction in patients with aphasia after stroke

Gene therapy: a viable therapeutic strategy for Parkinson’s disease?

Cold paresis in multifocal motor neuropathy

Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour

Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis